weight loss drug news today glp-1 Half of users ditch their injections — and some are turning to other weight-loss methods instead 🚨 GLP-1 WEIGHT LOSS DRUGS:

2022Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes

Management of Chronic Pain

Researchers in JAMA Network Open reviewed the total cost of producing GLP-1 medications (as well as insulin and another classes of medicines used for diabetes) with an eye toward establishing a resource-based price so that these medications could be used to treat obesity and diabetes in low and middle income countries, where noncommunicable diseases such as heart disease and diabetes take a larger toll each year

Everythingfrom how they are administered to how long their effects lastdepends on the type of GLP-1 molecule used

Over the next years, it will be important to understand the effect of the reduced circulating amino-acids with the novel multi-agonists targeting the glucagon receptor on lean muscle mass (especially in populations with obesity and high risk of sarcopenia) as well as on energy expenditure [66]

See if You Qualify The Ozempic Lawsuit is an active lawsuit See If You Qualify Ozempic and Gastroparesis Overview Litigation is pending against Novo Nordisk, the manufacturer of Ozempic, for allegedly not properly warning about the potentially severe gastrointestinal side effects related to its GLP-1 drugs